The drugmaker gave strong projections for the second quarter and got closer to completing its purchase of Allergan's generic drug business.
The health care security software maker agreed to be bought by the private equity firm Thoma Bravo for $19.25 per share, or about $488 million.
The airplane maintenance company posted weaker-than-expected results for its fiscal fourth quarter.
